Amneal Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segm…

Drug Manufacturers - Specialty & Generic
US, Bridgewater [HQ]

Lobbying Analysis

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
2024 3 $6,000,000 LD-2 : 10/18/24
2024 2 $6,000,000 LD-2 : 07/15/24
2024 1 $6,000,000 LD-2 : 04/16/24
End of AMRX's Analysis
CIK: 1723128 CUSIP: 03168L105 ISIN: US03168L1052 LEI: - UEI: -
Secondary Listings
AMRX has no secondary listings inside our databases.